Newly identified function for protein could hold key to chemo resistance

A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to ...

Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in ...

On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026TRX319 is an allogeneic CAR-Tr1 Treg cell therapy designed to pair ...
News-Medical.Net on MSN

Scientists revive diabetic beta cells, revealing a new path to restore insulin function

Researchers demonstrated that pancreatic β cells from type 2 diabetes donors can partially regain glucose responsiveness when ...
Hosted on MSN

Cells locally make two protein classes at mitochondria to support energy production

Our cells produce a variety of proteins, each with a specific role that, in many cases, means that they need to be in a particular part of the cell where that role is needed. One of the ways that ...

Whole new class of anti-ageing drug found to work at cell level

Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that ...

Galvanizing blood vessel cells to expand for organ transplantation

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the ...

Excellergy Debuts with $70 Million Series A Financing to Advance First-in-Class Portfolio of Trifunctional Effector Cell Response Inhibitors (ECRIs) for Complete Allergic Control

Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of ...

Alpha cells produce GLP-1, like Ozempic drugs, study finds

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics

Cell X Technologies today announced a collaboration with BioLamina to integrate BioLamina's defined laminin reagents (Biolaminin®) with Cell X's Celligent™ platform, aiming to reduce variability and ...